Evercore ISI analyst David Motemaden raised the firm’s price target on RenaissanceRe (RNR) to $283 from $250 and keeps an In Line rating on the shares. With a tough cyclical backdrop, 2026 is “shaping up to be a challenging year for the P&C insurance sector,” but this presents “a stock pickers market with opportunities for discerning investors,” the analyst says in a year-ahead outlook note for the group.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNR:
- RenaissanceRe price target raised to $329 from $303 at JPMorgan
- RenaissanceRe price target raised to $314 from $270 at Keefe Bruyette
- RenaissanceRe Extends Secured Letter of Credit Facility
- RenaissanceRe price target raised to $300 from $290 at Morgan Stanley
- RenaissanceRe initiated with a Neutral at Mizuho